B-cell responses to vaccination with BNT162b2 and mRNA-1273 6 months after second dose

OBJECTIVES: To examine the state of B-cell immunity 6 months after the second vaccination against SARS-CoV-2 in comparison to the state observed 2 weeks after vaccination. METHODS: Sera of 439 participants, whose immune responses to two doses of an mRNA-based vaccine (BNT162b2 or mRNA-1273) were pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Markewitz, Robert, Pauli, Daniela, Dargvainiene, Justina, Steinhagen, Katja, Engel, Sarah, Herbst, Victor, Zapf, Dorinja, Krüger, Christina, Sharifzadeh, Shahpour, Schomburg, Benjamin, Leypoldt, Frank, Rupp, Jan, Görg, Siegfried, Junker, Ralf, Wandinger, Klaus-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897957/
https://www.ncbi.nlm.nih.gov/pubmed/35259531
http://dx.doi.org/10.1016/j.cmi.2022.02.028

Ejemplares similares

Ejemplares similares